A Study of XZP-5955 Tablets in Patients With NTRK or ROS1 Fusion Positive Locally Advanced or Metastatic Solid Tumors

Clinical trial NCT04996121 · RECRUITING

Trial details

NCT number: NCT04996121
Sponsor: Xuanzhu Biopharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Solid Tumors Locally Advanced or Metastatic Non-small Cell Lung Cancer

Start date: 2021-12-06
Primary completion: 2025-09-01
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.